Guillain-Barre Syndrome Following Viral Infections: Considerations for Future Treatment and Research

Wang, Lili

doi:10.14218/erhm.2017.00035

Cited by 3 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…38 Guillain-Barré syndrome GBS can potentially be linked to any viral infection and is a documented complication found in previous viral pandemics, including those due to Zika, chikungunya, dengue, and H1N1 influenza viruses. 39 Due to the rising pandemics of SARS-CoV-2 infection since the early months of 2020, vigilance for signs and symptoms of GBS should be part of the assessment of patients with SARS-CoV-2 infection given that, although a rare event in general, GBS is a potentially treatable complication that may rise the viral infection lethality if not promptly identified.…”

Section: Encephalopathymentioning

confidence: 99%

Neurological complications in patients with SARS-CoV-2 infection: a systematic review

Munhoz

Pedroso

Nascimento

et al. 2020

Arq. Neuro-Psiquiatr.

109

View full text Add to dashboard Cite

Background: As the COVID-19 pandemic unfolds worldwide, different forms of reports have described its neurologic manifestations. Objective: To review the literature on neurological complications of SARS-CoV-2 infection. Methods: Literature search performed following systematic reviews guidelines, using specific keywords based on the COVID-19 neurological complications described up to May 10th, 2020. Results: A total of 43 articles were selected, including data ranging from common, non-specific symptoms, such as hyposmia and myalgia, to more complex and life-threatening conditions, such as cerebrovascular diseases, encephalopathies, and Guillain-Barré syndrome. Conclusion: Recognition of neurological manifestations of SARS-CoV-2 should be emphasized despite the obvious challenges faced by clinicians caring for critical patients who are often sedated and presenting other concurrent systemic complications.

show abstract

Section: Encephalopathymentioning

confidence: 99%

Neurological complications in patients with SARS-CoV-2 infection: a systematic review

Munhoz

Pedroso

Nascimento

et al. 2020

Arq. Neuro-Psiquiatr.

109

View full text Add to dashboard Cite

show abstract

“…Viral infections are frequently present before the clinical manifestation of Guillain-Barre syndrome (GBS) [ 1 ]. Antibodies against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) can cross-react with peripheral myelin causing GBS since these viruses have neurotropic characteristics, and their molecular mimicry can induce inflammatory demyelinating neuropathy [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

Occurrence of Guillain-Barre Syndrome During the Initial Symptomatic Phase of COVID-19 Disease: Coincidence or Consequence?

Seixas¹,

Campoamor²,

Lopes³

et al. 2021

Cureus

View full text Add to dashboard Cite

Viral infections are frequently present before the clinical manifestation of Guillain-Barre syndrome (GBS). Multiple studies on coronaviruses have shown that these viruses have neurotropic characteristics, and their molecular mimicry can induce inflammatory demyelinating neuropathy. Herein, we describe a case of a GBS in an 85-year-old patient infected with SARS-CoV-2, manifested with acute progressive symmetric ascending quadriparesis, urinary dysautonomia, and dysphagia, who responded well to treatment with intravenous human immunoglobulin.

show abstract

Microorganisms in Pathogenesis and Management of Guillain–Barré Syndrome (GBS)

Yadav

Pragati

Dwivedi

2022

Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases

View full text Add to dashboard Cite

Guillain-Barre Syndrome Following Viral Infections: Considerations for Future Treatment and Research

Cited by 3 publications

References 25 publications

Neurological complications in patients with SARS-CoV-2 infection: a systematic review

Neurological complications in patients with SARS-CoV-2 infection: a systematic review

Occurrence of Guillain-Barre Syndrome During the Initial Symptomatic Phase of COVID-19 Disease: Coincidence or Consequence?

Microorganisms in Pathogenesis and Management of Guillain–Barré Syndrome (GBS)

Contact Info

Product

Resources

About